Dr. Reddy’s Laboratories (NYSE: RDY) approves 15,933 ESOP grant at Rs. 1,206

Q: What stock options did Dr. Reddy’s (RDY) grant on July 22, 2026?

Dr. Reddy’s granted 15,933 stock options to an eligible employee under the Dr. Reddy’s Employees Stock Option Scheme, 2018 . The grant was approved by the Nomination, Governance and Compensation Committee through a circular resolution on July 22, 2026.

Q: What is the exercise price of the new Dr. Reddy’s (RDY) stock options?

The options carry an exercise price of Rs. 1,206 per stock option . This price is described as the Fair Market Value for the Indian Stock Options granted under the Dr. Reddy’s Employees Stock Option Scheme, 2018.

Q: What is the vesting schedule for the latest Dr. Reddy’s (RDY) ESOP grant?

The granted options provide 100% vesting at the end of 3 years . After this 3‑year period, the entire block of 15,933 stock options vests in favor of the eligible employee, in line with the terms of the 2018 ESOP.

Q: Is the new Dr. Reddy’s (RDY) ESOP grant compliant with SEBI regulations?

Yes. The company states the grant is in terms of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 . It is also disclosed under Regulation 30 of the SEBI (LODR) Regulations, 2015 , highlighting compliance-focused reporting.

Q: Which committee approved Dr. Reddy’s (RDY) July 2026 stock option grant?

The Nomination, Governance and Compensation Committee of the Board approved the grant by resolution passed through circulation. This committee administers the Dr. Reddy’s Employees Stock Option Scheme, 2018 , under which the 15,933 stock options were issued.

Q: How many shares of Dr. Reddy’s (RDY) are covered by the new stock options?

The grant covers 15,933 shares , as each stock option is exercisable into one equity share. These options are classified as Indian Stock Options and fall under the company’s 2018 employee stock option scheme framework.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited approved a grant of 15,933 stock options to an eligible employee under the Dr. Reddy’s Employees Stock Option Scheme, 2018. The Nomination, Governance and Compensation Committee cleared the grant by circular resolution dated July 22, 2026.

The options are Indian Stock Options with an exercise price of Rs. 1,206 per share. They provide 100% vesting at the end of 3 years and are governed by the 2018 ESOP in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Key Figures

Stock options granted: 15,933 options Exercise price: Rs. 1,206 per stock option Vesting period: 3 years +2 more

5 metrics

Stock options granted 15,933 options Grant of stock options to an eligible employee under ESOP 2018

Exercise price Rs. 1,206 per stock option Exercise price for Indian Stock Options granted on July 22, 2026

Vesting period 3 years 100% of options vest at the end of 3 years

Shares covered by options 15,933 shares Total number of shares underlying the granted options

Grant approval date July 22, 2026 Date of committee resolution approving the ESOP grant

Key Terms

Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, Nomination, Governance and Compensation Committee, Employees Stock Option Scheme, 2018

4 terms

Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 regulatory

"Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015"

Nomination, Governance and Compensation Committee regulatory

"the Nomination, Governance and Compensation Committee of the Board of Directors of the Company"

Employees Stock Option Scheme, 2018 financial

"Grant of 15,933 stock options under Dr. Reddy’s Employees Stock Option Scheme, 2018"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 07/22/2026 - 08:27 AM Accepted by SEC EDGAR 07/22/2026 - 08:27 AM

FAQ

What stock options did Dr. Reddy’s (RDY) grant on July 22, 2026?

Dr. Reddy’s granted 15,933 stock options to an eligible employee under the Dr. Reddy’s Employees Stock Option Scheme, 2018. The grant was approved by the Nomination, Governance and Compensation Committee through a circular resolution on July 22, 2026.

What is the exercise price of the new Dr. Reddy’s (RDY) stock options?

The options carry an exercise price of Rs. 1,206 per stock option. This price is described as the Fair Market Value for the Indian Stock Options granted under the Dr. Reddy’s Employees Stock Option Scheme, 2018.

What is the vesting schedule for the latest Dr. Reddy’s (RDY) ESOP grant?

The granted options provide 100% vesting at the end of 3 years. After this 3‑year period, the entire block of 15,933 stock options vests in favor of the eligible employee, in line with the terms of the 2018 ESOP.

Is the new Dr. Reddy’s (RDY) ESOP grant compliant with SEBI regulations?

Yes. The company states the grant is in terms of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. It is also disclosed under Regulation 30 of the SEBI (LODR) Regulations, 2015, highlighting compliance-focused reporting.

Which committee approved Dr. Reddy’s (RDY) July 2026 stock option grant?

The Nomination, Governance and Compensation Committee of the Board approved the grant by resolution passed through circulation. This committee administers the Dr. Reddy’s Employees Stock Option Scheme, 2018, under which the 15,933 stock options were issued.

How many shares of Dr. Reddy’s (RDY) are covered by the new stock options?

The grant covers 15,933 shares, as each stock option is exercisable into one equity share. These options are classified as Indian Stock Options and fall under the company’s 2018 employee stock option scheme framework.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

July, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit

Number

Description of Exhibits

99.1

Intimation dated July 22, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	DR. REDDY’S LABORATORIES LIMITED (Registrant)

Date: July 22, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

Exhibit 99.1

Dr. Reddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills

Hyderabad – 500 034, Telangana, India

CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900

Fax: + 91 40 4900 2999

Email: mail@drreddys.com

Web: www.drreddys.com

July 22, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Ltd. (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

This is to inform that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company vide resolution by circulation dated July 22, 2026, has approved the grant of stock options to the eligible employee under the Employees Stock Option Schemes of the Company:

Sl. No.

Type of Option(s)

Number of options granted

Value

Exercise Price per share

ESOP Scheme

Indian Stock Options

15,933

Fair Market Value

Rs. 1,206/-

Dr. Reddy’s Employees Stock Option Scheme, 2018

This is for your information and records.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K. Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

BRIEF DETAILS ON THE GRANT OF STOCK OPTIONS

(Pursuant to SEBI Master Circular No. HO/49/14/14(7)2025‐CFD‐POD2/I/3762/2026

dated January 30, 2026)

S.No	Particulars	Details
1.	Brief details of options granted	Grant of 15,933 stock options under Dr. Reddy’s Employees Stock Option Scheme, 2018, to the eligible employee of the Company.
2.	Whether the scheme is in terms of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (if applicable)	Yes
3.	Total number of shares covered by these options	15,933
4.	~~Pricing formula/ Exercise Price~~ / Grant Price	Rs. 1,206/- per stock option
5.	Options vested / vesting schedule	100% vesting at the end of 3 years
6.	Time within which option may be exercised	According to respective vesting schedule
7.	Brief details of significant terms	Stock options granted are governed under the Dr. Reddy’s Employees Stock Option Scheme, 2018, which is administered and implemented by the Nomination, Governance & Compensation Committee
8.	Options exercised	Not Applicable
9.	Money realized by exercise of options
10.	The total number of shares arising as a result of exercise of option
11.	Options lapsed
12.	Variation of terms of options
13.	Subsequent changes or cancellation or exercise of such options
14.	Diluted earnings per share pursuant to issue of equity shares on exercise of options

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document

Press Releases

EX-99.1 EXHIBIT 99.1 71.1 KB